Allarity Therapeutics ALLR
NASDAQ ALLR
$1.42 -0.01 (-0.70%)
At close: Aug 21, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Gains from Investment Securities (2020 - 2023)

Allarity Therapeutics' (ALLR) quarterly Gains from Investment Securities came in at $591000.0 in Q3 2023, up 116.48% on a QoQ basis from $273000.0 in Q2 2021.

Allarity Therapeutics (ALLR) Gains from Investment Securities (2020 - 2023) Analysis & Trends

Allarity Therapeutics (ALLR) has 3 years of Gains from Investment Securities data on file, last reported at $591000.0 in Q3 2023.

  • Quarterly Gains from Investment Securities changed N/A year-over-year to $591000.0 in Q3 2023, while the trailing twelve-month figure through Dec 2024 was $591000.0 (changed 0.0% YoY) and the FY2023 annual result came in at $591000.0, up 58.02% from the prior year.
  • Gains from Investment Securities grew to $591000.0 in Q3 2023, from $273000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $591000.0 in Q3 2023 to a low of $20000.0 in Q4 2020.
  • A 3-year average of $271250.0 and a median of $237000.0 in 2021 frame the typical range for Gains from Investment Securities.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Allarity Therapeutics 22.75 Mn 22.75 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2023 591,000.00
Sep 30, 2023 591,000.00
Jun 30, 2021 273,000.00
Jun 30, 2021 273,000.00
Mar 31, 2021 201,000.00
Mar 31, 2021 201,000.00
Dec 31, 2020 20,000.00
Dec 31, 2020 20,000.00